ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

LLY Eli Lilly and Co

808.25
-0.20 (-0.02%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,778,122
Bid Price
Ask Price
News (3)
Day High 811.69

Low
419.80

52 Week Range

High
820.605

Day Low 804.15
Company Name Stock Ticker Symbol Market Type
Eli Lilly and Co LLY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.20 -0.02% 808.25 20:00:00
Open Price Low Price High Price Close Price Prev Close
810.75 804.15 811.69 807.43 808.45
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
65,154 1,778,122 $ 808.55 $ 1,437,706,126 - 419.80 - 820.605
Last Trade Time Type Quantity Stock Price Currency
19:59:44 1 $ 808.30 USD

Eli Lilly (LLY) Options Flow Summary

Overall Flow

Bullish

Net Premium

82M

Calls / Puts

627.19%

Buys / Sells

110.93%

OTM / ITM

66.81%

Sweeps Ratio

0.01%

Eli Lilly and Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
767.19B 950.16M - 34.12B 5.24B 5.52 146.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Eli Lilly News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LLY Message Board. Create One! See More Posts on LLY Message Board See More Message Board Posts

Historical LLY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week771.68820.605766.12796.582,564,89236.574.74%
1 Month724.00820.605721.00771.692,887,94284.2511.64%
3 Months769.27820.605718.30765.532,719,08338.985.07%
6 Months598.36820.605561.65701.792,954,782209.8935.08%
1 Year423.88820.605419.80614.722,984,422384.3790.68%
3 Years201.19820.605195.50402.902,987,815607.06301.73%
5 Years116.83820.605101.36284.843,313,196691.42591.82%

Eli Lilly Description

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer.

Your Recent History

Delayed Upgrade Clock